vaccine

Valneva SE (NASDAQ:VALN) on Thursday announced six-month antibody persistence and safety data for its Phase 2 trial evaluating the safety and immunogenicity of two different dose levels of its single-shot chikungunya vaccine, Ixchiq, in 304 children, according to a press release. Partially funded...

The President Donald Trump administration terminated a nearly $600 million contract to Moderna Inc. (NASDAQ:MRNA) for developing an mRNA-based bird flu vaccine, ending a key former President Joe Biden-era pandemic preparedness initiative. What Happened: Health and Human Services officials canceled...

Moderna Inc. (NASDAQ:MRNA) reported on Thursday a first-quarter EPS loss of $(2.52), missing the consensus of $(3.12), down from an EPS loss of $(3.07) a year ago. The COVID-19 vaccine maker reported quarterly sales of $108 million, down from $167 billion a year ago, beating the consensus of $...

The Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to Valneva SE’s (NASDAQ:VALN) single-dose vaccine Ixchiq for the prevention of disease caused by the chikungunya virus in individuals 18 years of age and older. Chikungunya virus is a mosquito-borne viral...

Pfizer Inc. (NYSE:PFE) shares are trading lower on Wednesday after a Wall Street Journal report revealed U.S. prosecutors are investigating a claim about the timing of Pfizer's COVID-19 vaccine announcement. What To Know: The claim, brought forward by British pharmaceutical company GSK, alleges...

Robert F. Kennedy Jr.‘s appointment as U.S. Secretary of Health and Human Services has sparked concerns over funding for the National Institutes of Health. Analysts warn that potential cuts to this funding could lead to increased “uncertainty” in the healthcare sector, potentially...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Moderna, Inc. (NASDAQ:MRNA) have reached a stipulation in their ongoing patent infringement litigation. In 2022, Alnylam filed a patent infringement lawsuit against Moderna, claiming it violated a newly obtained patent. The claim is over mRNA...

Bill Gates, co-founder of Microsoft, has addressed the widespread conspiracy theory that accuses him of implanting microchips in COVID-19 vaccines. What Happened: Gates was once confronted by a woman who believed in this theory. To this, Gates responded, “I really don’t need to track...

The World Health Organization (WHO) has declared mpox, a viral infection, a global public health emergency. This is the second such declaration in two years due to a new outbreak spreading across Africa. What Happened: The WHO made the declaration following an outbreak of the viral infection in the...

In response to the growing threat of the H5N1 bird flu virus, the U.S. government has awarded a $176 million contract to Moderna Inc. (NASDAQ:MRNA) to accelerate the development of its bird flu vaccine. What Happened: Moderna revealed on Tuesday that it had received significant funding from the U.S...

A promising new startup, Ovax Inc., secured $10 million in funding to advance the development of a groundbreaking vaccine designed to prevent fentanyl-related deaths. The initiative focuses on commercializing academic research aimed at preventing the potent opioid from reaching the brain, reported...

AstraZeneca (NASDAQ:AZN) has declared a worldwide cessation of its COVID-19 vaccine, Vaxzevria, due to an “excess of updated vaccines.” What Happened: The company began the withdrawal process on Tuesday, attributing the decision to the proliferation and availability of multiple variants...

CureVac N.V. (NASDAQ:CVAC) released interim data on Thursday, April 4, from studies it conducted on its seasonal influenza vaccine candidate. The study is part of a collaboration with GSK Plc (NYSE:GSK).  The multivalent candidate was selected from a comprehensive Phase 1 part, which tested vaccine...

During a recent hearing on vaccine safety, Rep. Marjorie Taylor Greene (R-Ga.) made controversial statements that have drawn criticism from her Democratic colleagues. What Happened: Greene, who is not a medical professional, said, "I'm not a doctor, but I have a Ph.D. in recognizing bulls*...

Key Takeaways: Clover Biopharmaceuticals posted a surge in first-half earnings after a $384 million grant for Covid vaccine development was belatedly folded into its accounts The company has turned its attention to flu vaccines after being hit by waning demand in the crowded Covid market By Molly...